Company Overview
Company Type: Private Company
Website: www.rapidnovor.com
Number of Employees: 32
Year Founded: 2015
Total Amount Raised (CAD mm)†: 6.69
Total Rounds of Funding**:1
Latest Post-Money Valuation ($ mm) -
Latest Pre-Money Valuation ($ mm) -
† This number reflects the estimated value of the total new money raised through private placement rounds.
** This value is an estimate of the total number of funding rounds this company has received.


Business Description
Rapid Novor, Inc. engages in the research and development of antibody protein sequencing and mass spectrometry-based proteomics technology. The company offers REmAb antibody sequencing platform for the identification of amino acids in the antibody sequence; and REmAb + WILD technology methods for distinguishing isomeric residues, including Isoleucine and Leucine. It also offers REpAb platform for immunoassays and monoclonal antibodies discovery through polyclonal antibodies (pAb) sequencing; NovorIg technology for quantification and analysis of immune response; and De Novo protein sequencing services through WILD method. The company was incorporated in 2015 and is based in Kitchener, Canada.


Financial Information (Currency: CAD, in mm)
Total Revenue
 8.0
Operating Income
-
Total Assets
-
Gross Profit
-
EBITDA
-
Total Debt
-
Net Income
-
Estimated Number of Employees
 32
Net Debt
-
* Hover over data point numbers for date and source.

Key Professionals
Name
Title
Xie, Mingjie 
Chief Executive Officer
Ma, Bin 
President & Chief Scientist
Liu, Qixin 
Chief Technology Officer
Rogers, Iain 
Vice President of Sales & Marketing
Nemeth, Frank 
Human Resources Manager
Yang, Liqiang 
Chief Strategy Officer


Primary Industry Classification
Biotechnology


Primary Office Location
Unit 450 137 Glasgow St. | Kitchener, ON | N2G 4X8 | Canada
Phone: 855-899-9990   

Current and Pending Investors
Investor
Initial Investment Date
Stake Type
Current Stake Amount
Round(s)
Investment Coverage
Suzhou Kaifeng Zhengde Investment Management Co., Ltd.
Jul-28-2020
Minority
-
Series A
Gang Wen

Prior Investors
Accelerator Centre


Company Notes
No Company Notes exist.


Strategy Notes
No Strategy Notes exist.


Last 5 Transactions
Announced Date
Closed Date
Transaction Type
Role
Target
Buyer/Investors
Sellers
Size($mm)
Jul-28-2020
Jul-28-2020
Private Placement
Target
Rapid Novor, Inc.
Suzhou Kaifeng Zhengde Investment Management Co., Ltd.

5.00
* denotes that the relationship is proprietary


Last 5 Key Developments
Date
Event Type
Headline
May-15-2023
Company Conference Presentations
Rapid Novor, Inc. Presents at PEGS Boston Summit 2023, May-15-2023
Jan-09-2023
Company Conference Presentations
Rapid Novor, Inc. Presents at Biotech Showcase 2023, Jan-09-2023
Jan-17-2022
Company Conference Presentations
Rapid Novor, Inc. Presents at PepTalk 2022, Jan-17-2022
Jun-09-2021
Company Conference Presentations
Rapid Novor, Inc. Presents at Antibody Engineering & Therapeutics Europe, Jun-09-2021 09:30 AM
Jul-28-2020
Private Placements
Rapid Novor Inc announced that it has received $5 million in funding from Suzhou Kaifeng Zhengde Investment Management Co., Ltd.


Last 10 Investment Research Documents
Contributor
Analyst
Date/Time
Company
Headline
Type
Pages
GlobalData

Sep 20, 2023 05:04 AM
Rapid Novor, Inc.
Rapid Novor Inc
Reports
28
GlobalData

Dec 13, 2022 12:18 AM
Rapid Novor, Inc.
Rapid Novor Inc
Reports
26
GlobalData

Sep 23, 2022 06:57 PM
Rapid Novor, Inc.
Rapid Novor Inc
Reports
26
GlobalData

Jun 14, 2022 02:59 AM
Rapid Novor, Inc.
Rapid Novor Inc
Reports
26
GlobalData

Mar 17, 2022 04:09 AM
Rapid Novor, Inc.
Rapid Novor Inc
Reports
26
GlobalData

Dec 17, 2021 01:08 AM
Rapid Novor, Inc.
Rapid Novor Inc
Reports
25
GlobalData

Sep 17, 2021 10:55 AM
Rapid Novor, Inc.
Rapid Novor Inc
Reports
16
GlobalData

Jun 11, 2021 09:44 PM
Rapid Novor, Inc.
Rapid Novor Inc
Reports
16
GlobalData

Dec 10, 2020 02:35 AM
Rapid Novor, Inc.
Rapid Novor Inc
Reports
20
GlobalData

Sep 10, 2020 03:27 AM
Rapid Novor, Inc.
Rapid Novor Inc
Reports
20


S&P Global Ratings Credit Ratings
No S&P Global Ratings Credit Ratings data available. 


News Headlines
No News is currently available for the selected sources.


Company Coverage
This company is not on any Coverage List.


Upcoming Events
Date/Time
Type
Nov-13-2023
Conferences
Nov-14-2023
Company Conference Presentations
Nov-14-2023
Company Conference Presentations
* Future Events are subject to change.

Key Executives and Professionals Details
Name
Title
Phone
Fax
Email
Xie, Mingjie 
Chief Executive Officer
855-899-9990
-

Ma, Bin 
President & Chief Scientist
855-899-9990
-

Liu, Qixin 
Chief Technology Officer
855-899-9990
-

Rogers, Iain 
Vice President of Sales & Marketing
855-899-9990
-

Nemeth, Frank 
Human Resources Manager
855-899-9990
-

Yang, Liqiang 
Chief Strategy Officer
855-899-9990
-

* denotes that the relationship is proprietary

S&P Credit Ratings and Research provided by 
No content (including ratings, credit-related analyses and data, valuations, model, software or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of S&P Global Market Intelligence or its affiliates (collectively, S&P Global). The Content shall not be used for any unlawful or unauthorized purposes. S&P Global and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively S&P Global Parties) do not guarantee the accuracy, completeness, timeliness or availability of the Content. S&P Global Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an "as is" basis. S&P GLOBAL PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT’S FUNCTIONING WILL BE UNINTERRUPTED OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Global Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages.

Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P Global Market Intelligence’s opinions, analyses and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P Global Market Intelligence assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. S&P Global Market Intelligence does not act as a fiduciary or an investment advisor except where registered as such. While S&P Global Market Intelligence has obtained information from sources it believes to be reliable, S&P Global Market Intelligence does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives.

S&P Global keeps certain activities of its divisions separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain divisions of S&P Global may have information that is not available to other S&P Global divisions. S&P Global has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.

S&P Global Ratings does not contribute to or participate in the creation of credit scores generated by S&P Global Market Intelligence. Lowercase nomenclature is used to differentiate S&P Global Market Intelligence PD credit model scores from the credit ratings issued by S&P Global Ratings.

S&P Global may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P Global reserves the right to disseminate its opinions and analyses. S&P Global's public ratings and analyses are made available on its Web sites, www.standardandpoors.com (free of charge), and www.capitaliq.com (subscription), and may be distributed through other means, including via S&P Global publications and third-party redistributors. Additional information about our ratings fees is available at www.standardandpoors.com/usratingsfees.
Regulatory News Service data provided by 
